AmpliPhi Biosciences Corporation
(AmpliPhi) is a biotechnology company dedicated to the development of
antibacterial solutions to improve human health through the application
of its proprietary bacteriophage platform.
lead product development
programs target Gram negative bacterial infections that are often
to existing antibiotic treatments. They include BioPhage-PA for the
of chronic inner ear infections and BioPhage-PR, for the treatment of
infections in cystic fibrosis patients.
is also exploring
product development opportunities to combine bacteriophage-based
with conventional antibiotics and develop multi-target,
therapeutics through the application of its bacteriophage technology
its established and expanding phage bank applicable to a range of
multiple research grants to support portions of its product development
programs. These include grant funding from the Cystic Fibrosis
of America to support clinical trials of BioPhage-PR.
in Seattle, Washington and in Colworth Science Park, near London in the
Olive Way Suite 100
States - Map